Aoxing Pharmaceutical Company Inc (AOXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,337 | 1,348 | 5,495 | 1,337 | 559 |
| Depreciation Amortization | 529 | 268 | 666 | 814 | 548 |
| Income taxes - deferred | 1,270 | 885 | -2,704 | N/A | N/A |
| Accounts receivable | -1,104 | -1,459 | -1,735 | -2,512 | -507 |
| Accounts payable and accrued liabilities | -2,677 | -561 | 1,352 | 3,812 | -797 |
| Other Working Capital | -6,237 | -2,336 | -805 | 3,111 | 2,211 |
| Other Operating Activity | 4,167 | 2,244 | 758 | -1,413 | 1,354 |
| Operating Cash Flow | $-715 | $390 | $3,026 | $5,148 | $3,368 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -91 | -82 | -2,705 | -3,008 | -2,938 |
| Investing Cash Flow | $-91 | $-82 | $-2,705 | $-3,008 | $-2,938 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 1,029 | N/A | -2,060 |
| Debt Issued | 1,363 | 1,376 | 9,407 | N/A | 6,502 |
| Debt Repayment | -473 | -478 | N/A | 933 | -11,709 |
| Common Stock Issued | 2,739 | 2,739 | 2,424 | 1,396 | 5,817 |
| Other Financing Activity | -764 | -671 | -10,187 | -2,060 | 0 |
| Financing Cash Flow | $2,865 | $2,966 | $2,673 | $269 | $-1,451 |
| Exchange Rate Effect | -995 | -474 | 49 | 49 | 31 |
| Beginning Cash Position | 5,372 | 5,372 | 2,330 | 2,330 | 2,330 |
| End Cash Position | 6,435 | 8,172 | 5,372 | 4,787 | 1,340 |
| Net Cash Flow | $1,064 | $2,800 | $3,042 | $2,457 | $-990 |
| Free Cash Flow | |||||
| Operating Cash Flow | -715 | 390 | 3,026 | 5,148 | 3,368 |
| Capital Expenditure | -91 | -82 | -2,705 | -3,008 | -2,938 |
| Free Cash Flow | -805 | 309 | 320 | 2,140 | 430 |